Drug adverse events and system complications of intrathecal opioid delivery for pain: Origins, detection, manifestations, and management

Neuromodulation

Volumn 2, Issue 2, 1999, Pages 92-107

  Naumann, Claus ^a,f   Erdine, Serdar ^b,c   Koulousakis, Athanasios ^b,c   Van Buyten, Jean Pierre ^d   Schuchard, Marilee ^e  

^a Swiss Cancer Institute   (Switzerland)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d AZ Maria Middelares   (Belgium)

^e Sunshine Anesthesia and Pain Treatment   (United States)

^f Pain Center   (Switzerland)

Author keywords

Complications; Intrathecal delivery; Opioids; Pain; Side effects

Indexed keywords

ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BACLOFEN; BENZODIAZEPINE; BETHANECHOL; BUPIVACAINE; BUPRENORPHINE; CAFFEINE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CORTICOSTEROID; ESTROGEN; FENTANYL; HALOPERIDOL; HYDROMORPHONE; LAXATIVE; METHYLPHENIDATE; METOCLOPRAMIDE; MORPHINE DERIVATIVE; NALBUPHINE; NALOXONE; NALTREXONE; OPIATE AGONIST; PROCHLORPERAZINE; TERAZOSIN; TESTOSTERONE CIPIONATE; UNINDEXED DRUG;

ADVERSE DRUG REACTION; ARTICLE; BLEEDING; CATHETER; CATHETER INFECTION; COGNITIVE DEFECT; DRUG DELIVERY SYSTEM; EDEMA; ENDOCRINE DISEASE; EPIDURAL DRUG ADMINISTRATION; GASTROINTESTINAL TOXICITY; HUMAN; IATROGENIC DISEASE; INFUSION PUMP; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MENINGITIS; ORAL DRUG ADMINISTRATION; PAIN; POSTOPERATIVE COMPLICATION; PRURITUS; RESPIRATION DEPRESSION; SEDATION; SEROMA; SEXUAL DYSFUNCTION; SKIN NECROSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE; URINE RETENTION;

EID: 0033000637     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.1999.00092.x     Document Type: Article

References (74)

1. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guide-lines. J Pain Symptom Manage 1996;11:333-352.
2. LaMotte C, Pert CB, Snyder SH. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res 1976;112:407-412.
3. Chaney MA. Review article. Side effects of intrathecal and epidural opioids. Can J Anaesth 1995;42: 891-903.
4. Coombs DW, Saunders RL, Gaylor MS, Pageau M, Leith MG, Shaiberger C. Continuous epidural analgesia via implanted morphine reservoir. Lancet 1981;2:425-426.
5. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981;56:516-520.
6. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 1984;61: 276-310.
7. Morgan M. The rational use of intrathecal and extradural opioids. Br J Anaesth 1989;63:165-188.
8. de Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E. Cost-effectiveness of long-term intrathe cal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997;19:96-112.
9. Paice JA, Winkelmuller W, Burchiel K, Racz GB, Prager JP. Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage 1997;14 (Suppl):14-26.
10. Mueller-Schwefe G. Criteria for measuring out-comes of intrathecal therapy. Presented at 4th International Congress of the International Neuromodulation Society; September 20 1998; Lucerne, Switzerland.
11. th World Congress 1998.
12. Verhelst J, Abs R. Side effects of intrathecal opioid therapy and their management. State of the Art in the Use of Intrathecal Therapy for Chronic Pain. Presented at the Satellite Symposium of The International Neuromodulation Society; September 15-16, 1998; Lucerne, Switzerland.
13. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-80.
14. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85:458-467.
15. Bailey PL, Rhondeau S, Schafer PG et al. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology 1993;79:49-59.
16. Bromage PR, Camporesi EM, Durant PAC, Nielsen CH. Nonrespiratory side effects of epidural morphine. Anesth Analg 1982;61:490-495.
17. Fuller JG, McMorland GH, Douglas MJ, Palmer L. Epidural morphine for analgesia after Caesarean section: a report of 4880 patients. Can J Anaesth 1990; 37:636-640.
18. Rawal N, Arner S, Gustafsson LL, Allvin R. Present state of extradural and intrathecal opioid analgesia in Sweden. Br J Anaesth 1987;59:791-799.
19. Arner S, Rawal N, Gustafsson LL. Clinical experience of long-term treatment with epidural and intrathecal opioids-a nationwide survey. Acta Anaesthesiol Scand 1988;32:253-259.
20. Ballantyne JC, Loach AB, Carr DB. Review article. Itching after epidural and spinal opiates. Pain 1988;33: 149-160.
21. Scott PV, Fischer HBJ. Intraspinal opiates and itching: a new reflex? BWJ 1982;284:1015-1016.
22. Levy M. Pharmacologic treatment of cancer pain. N Engl J Med 1996;335:1124-1132.
23. Snyder SH. Opiate receptors in the brain. N Engl J Med 1977;296:266-271.
24. Wang SC, Borison HL. The vomiting center. Arch Neurol Psychiatry 1950;63:928-941.
25. Wattwil M. Postoperative pain relief and gastrointestinal motility. Acta Chir Scand 1988;550 (Suppl): 140-145.
26. Martin R, Salbaing J, Blaise G, Tetrault JP, Tetreault L. Epidural morphine for postoperative pain relief: a dose-response curve. Anaesthesiology 1982;56: 423-426.
27. Stenseth R, Sellevold O, Breivik H. Epidural morphine for postoperative pain: experience with 1085 patients. Acta Anaesthesiol Scan 1985;29:148-156.
28. Rawal N, Mollefors K, Axelsson K, Lingrdh G, Widman B. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal. Anesth Analg 1983;62:641-647.
29. Lanz E, Theiss D, Riess W, Sommer U. Epidural morphine for postoperative analgesia: a double-blind study. Anesth Analg 1982;61:236-240.
30. Petersen TK, Husted SE, Rybro L, Schurizek BA, Wernberg M. Urinary retention during LM. & extradural morphine analgesia. Br J Anaesth 1982;54:1175-1178.
31. Paice JA, Magolan JM. Intraspinal drug therapy. Nurs Clin N Am 1991;26:490.
32. Erdine Soztakcin S, Yucel A. Intrathecal morphine delivered by implanted manual pump for cancer pain. Pain Digest 1996;6:161-165.
33. Abboud TK, Moore M, Zhu J et al. Epidural butorphanol or morphine for the relief of post-cesarean section pain: ventilatory responses to carbon dioxide. Anesth Analg 1987;66:887-893.
34. 2 following epidural morphine. Anestheslology 1983;58:418-427.
35. Jacox A, Carr DB, Payne R et al. Management of Cancer Pain. Clinical Practice Guideline no. 9. Rockville, Md: Agency for Health Care Policy and Research; US Dept of Health and Human Services, Public Health Service; AHCPR publication 94-0592, 1994.
36. Etches RC, Sandler AN, Daley MD. Respiratory depression and spinal opioids. Can J Anaesth 1989;36: 165-185.
37. Waldman SD, Leak DW, Kennedy LD, Patt RB. Intraspinal opioid therapy. In: Patt RB, ed. Cancer Pain. Philadelphia: J. B. Lippincott Company; 1993:285-328.
38. Levy MH. Pharmacologic management of cancer pain. Semin Oncol 1994;21:718-739.
39. Cherny NI. Opioid analgesics: comparative features and prescribing guidelines. Drugs 1996;51: 713-737.
40. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncan cer origin. So Med J 1996;89:295-300.
41. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9: 126-131.
42. Chambers FA, MacSullivan R. Intrathecal morphine in the treatment of chronic intractable pain. Ir J Med Sci 1994;163:318-321.
43. Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993;45:43-85.
44. Bruera E, Brenneis C, Paterson AH, MacDonald RN. Use of methylphenedate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage 1989;4:3-6.
45. Follett KA, Hitchon PW, Piper J, Kumar V, Clamon G, Jones MP. Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 1992; 49:21-25.
46. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8:36-46.
47. Prager JR. Complications of implantation, diagnosis and management. Presented at Interventional Therapies Workshop, Dannemiller Memorial Educational Foundation. September 22 1996; Memphis, TN.
48. Brazenor GA. Long-term intrathecal administration of morphine: A comparison of bolus injection via reservoir with continuous infusion by implanted pump. Neurosurgery 1987;21:484-491.
49. Follett KA, Hitchon PW, Piper J, Kumar V, Clamon G, Jones MP. Response of intractable pain to continuous intrathecal morphine: A retrospective study. Pain 1992; 49:21-25.
50. Coombs DW, Maurer LH, Saunders RL, Gaylor M. Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. J Clin Oncol 1984;2:1414-1420.
51. Gestin Y, Vainio A, Pegurier AM. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 1997;41:12-17.
52. Aldrete JA, Vascello LA, Ghaly R, Tomlin D. Paraplegia in a patient with an intrathecal catheter and a spinal cord stimulator. Anesthesiology 1994;81: 1542-1545.
53. Bejjani GK, Karim NO, Tzortzidis F. Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol 1997; 48:288-291.
54. Blount JR Remley KB, Yue SK, Erickson DL. Intrathecal granuloma complicating chronic spinal infusion of morphine: report of three cases. J Neurosurg 1996; 84:272-276.
55. North RB, Cutchis PN, Epstein JA, Long DM. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurg 1991;29:778-784.
56. Schuchard M, Krames ES, Lanning R. Intraspinal analgesia for nonmalignant pain: a retrospective analysis for efficacy, safety, and feasibility in 50 patients. Neuromodulation 1998;1:46-56.
57. Sjoberg M, Karlsson PA, Nordbog C et al. Neuropathologic findings after long term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology 1992;76:173-186.
58. Schuchard M, Lanning R, North R, Reig E, Krames E. Neurologic sequelae of intraspinal drug delivery systems: results of a survey of American implanters of implantable drug delivery systems. Neuromodulation 1998;1:137-148.
59. Data on file. Medtronic, Inc., 1999. Available at: www.medtronic.com
60. Choi A, Laurito CE, Cunningham FE. Pharmacologic management of postdural puncture headache. Ann Pharmacotherapy 1996;30:831-839.
61. Sechzer PH, Abel L. Post-spinal anaesthesia headache treated with caffeine. Part I. Evaluation with demand method. Curr Ther Res 1978;24:307-312.
62. Sechzer PH. Post-spinal anesthesia headache treated with caffeine. Part II. Intracranial vascular distension, a key factor. Curr Ther Res 1979;26:440-448.
63. Jarvis AP, Grenawalt JW, Fagraeus L. Intravenous caffeine for postdural puncture headache. Anesth Analg 1986;65:316-317.
64. Camann WR, Murray RS, Mushlin PS, Lambert DH. Effects of oral caffeine on postdural puncture headache: a double-blind, placebo-controlled trial. Anesth Analg 1990;70:181-184.
65. Feuerstein TJ, Zeides A. Theophylline relieves headache following lumbar puncture: placebo-controlled, double-blind pilot study. Klin Wochenschr 1986; 64:216-218.
66. Carp H, Singh PJ, Vadhera R, Jayaram A. Effects of serotonin-receptor agonist sumatriptan on postdural puncture headache: report of six cases. Anesth Analg 1994;79:180-182.
67. Racz G. Subdural blood patch for treatment of spinal headache. Pain Digest 1997;7:211-213.
68. Shantha TR, Biese J. Subdural blood patch for spinal headache. N Engl J Med 1991;325:1252-1254. Letter.
69. Krames ES, Lanning RM. Intrathecal analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993;8:539-548.
70. Belmans L, Van Buyten JP. Accidental overdosing with intraspinal morphine caused by misprogrammation of a Synchromed pump: a report of two cases. Acta Anesthesiologica Belgica 1997;48:93-97.
71. Penn RD, York MM, Paice JA. Catheter systems for intrathecal drug delivery. J Neurosurg 1995;83:215-217.
72. Penn RD. Catheter implant systems for intrathecal drug delivery. J Neurosurg 1996;84:713.
73. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage in press.
74. Gybels J, Erdine S, Maeyaert J, Meyerson B, Winkelmuller W, Augustinsson L et al. Neuromodulation of pain. Eur J Pain 1998;2:203-209.